Stand Up to Cancer

The American Association for Cancer Research annual meeting wrapped up today in Chicago. Below are selected business briefs from the conference.

Stand Up to Cancer is teaming with Microsoft and SITC to provide a new round of $11 million in grants to study cancer immunotherapies.

The initiative's four research projects will use use genetic and other technologies to detect and treat cancer at its earliest stages.

NEW YORK (GenomeWeb News) –The fundraising organization Stand Up To Cancer (SU2C) has provided a grant of €6 million ($8.1 million) to investigators at the Dutch Cancer Society and the American Association for Cancer Research to fund an effort to grow and study living tumors from patient samples

NEW YORK (GenomeWeb News) – A multi-organization initiative has been created with the goal of discovering new therapies for childhood cancers using genomics as well as immunotherapeutic technologies.

NEW YORK (GenomeWeb News) – The Prostate Cancer Foundation plans to use a $7 million donation from New York billionaire Stewart Rahr to fund a multi-partner research project that will use genomic medicine and other approaches to discover new prostate cancer treatments.

NEW YORK (GenomeWeb News) – A second Dream Team project has been created for translational research into prostate cancer with $10 million in funding over three years.

NEW YORK (GenomeWeb News) – A group of Dutch-led research partners will use a €1.2 million ($1.5 million) grant awarded under a collaboration with Stand Up 2 Cancer (SU2C) to fund a genomics-based project seeking to use tumor profiles to predict patient response to cancer treatments.

The multi-partner non-profit cancer research initiative has funded new high-risk, high-reward grants using exome sequencing, genomic analysis, and tumor-specific drug response studies.

These high-risk awards for young scientists will support epigenomics, molecular profiling, and other studies that could be "game-changers."

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.